As GLP-1 RA use soars, experts are worried that patients may not be getting the right nutrients in their diets. How can ...

Maridebart cafraglutide, a novel injectable GLP-1 receptor agonist/GIP receptor antagonist, reduced body weight by up to ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

As usage of the medications increases, Circana research indicates deli and produce could be bright spots for spending.

Weight loss drugs have risen in popularity in the recent years, but a disconnect remains between those who need the drugs and ...

Holiday weight gain hits home for many come January. These days, folks making resolutions to slim down and get fit have an ...

Medspas are leading the charge in offering GLP-1 treatments, with 60% of medspas in the U.S. now providing these services, compared to 35% of aesthetic physician offices. Average spend per patient ...

Hims offers convenient and affordable access to treatments and products tailored for men's health needs. But how much does it ...

Highmark Health President and CEO David Holmberg discussed the uncertainties facing the insurance industry, including the ...

Topline data were announced from the AUDACITY trial evaluating the Allurion Gastric Balloon, a swallowable, procedureless intragastric balloon, in adults with obesity.

Allurion Technologies, Inc. , a company dedicated to ending obesity, today announced topline results from the AUDACITY Food & Drug Administration (FDA) pivotal trial evaluating the safety and efficacy ...

Experimental weight-loss drug Retatrutide shows promise, helping obese adults lose up to 22% of their weight in 48 weeks.